Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oikawa, Y.
Right arrow Articles by Saruta, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oikawa, Y.
Right arrow Articles by Saruta, T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 25:1818-1823, 2002
© 2002 by the American Diabetes Association, Inc.


Pathophysiology/Complications
Original Article

High Frequency of V{alpha}24+ Vß11+ T-Cells Observed in Type 1 Diabetes

Yoichi Oikawa, MD1, Akira Shimada, MD1, Satoru Yamada, MD1, Yoshiko Motohashi, MD1, Yoshinori Nakagawa, MD1, Jun-ichiro Irie, MD1, Taro Maruyama, MD2 and Takao Saruta, MD1

1 Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
2 Department of Internal Medicine, Saitama Social Insurance Hospital, Saitama, Japan

OBJECTIVE—Natural killer T-cells (NKT cells) are believed to play an important role in the regulation of immune response, and a numerical and functional deficit of NKT cells has been reported to be associated with the pathogenesis of autoimmune diseases. Thus far, it has been shown that subjects with type 1 diabetes have a lower frequency of NKT cells than nondiabetic subjects. In this study, we measured the frequency of peripheral V{alpha}24+ Vß11+ T-cells, which include human NKT cells, in Japanese diabetic patients.

RESEARCH DESIGN AND METHODS—Peripheral blood samples were obtained from 164 Japanese diabetic patients and 67 healthy subjects. The diabetic patients were classified into four categories as follows: islet-associated autoantibody–positive (Ab+) and –negative (Ab) classic type 1 diabetes, latent autoimmune diabetes in adults (LADA), and type 2 diabetes. We measured the frequency of peripheral V{alpha}24+ Vß11+ CD3+ triple-positive cells.

RESULTS—Unexpectedly, a higher frequency of V{alpha}24+ Vß11+ T-cells was observed in Ab+ and Ab- patients compared with LADA patients (P = 0.0294 and P = 0.0021), type 2 diabetic patients (P < 0.0001 and P < 0.0001), and healthy subjects (P = 0.0046 and P = 0.0001). Moreover, an inverse correlation between V{alpha}24+ Vß11+ T-cell frequency and disease duration was observed in Ab+ ({rho} = -0.455; P = 0.0023) and Ab- ({rho} = -0.432; P = 0.0162) patients.

CONCLUSIONS—Our findings indicate that a high frequency of V{alpha}24+ Vß11+ T-cells is a unique finding in recent-onset classic type 1 diabetes, and measurement of V{alpha}24+ Vß11+ T-cell frequency may be useful to assess the disease activity of classic type 1 diabetes.

Abbreviations: {alpha}-GalCer, {alpha}-galactosylceramide • Ab+, islet-associated autoantibody positive • Ab-, islet-associated autoantibody negative • FITC, fluorescein isothiocyanate • GADA, glutamic acid decarboxylase antibody • IA2A, insulinoma-associated protein-2 antibody • IFN-{gamma}, interferon-{gamma} • IL, interleukin • IP-10, interferon-inducible protein-10 • LADA, latent autoimmune diabetes in adults • MHC, major histocompatibility complex • NKT cells, natural killer T-cells • PC5, phycoerythrin-cyanine 5 • PE, phycoerythrin • TCR, T-cell receptor • Th, T helper


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
J. Kis, P. Engelmann, K. Farkas, G. Richman, S. Eck, J. Lolley, H. Jalahej, M. Borowiec, S. C. Kent, A. Treszl, et al.
Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus
J. Leukoc. Biol., March 1, 2007; 81(3): 654 - 662.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Duarte, M. Stenstrom, S. Campino, M.-L. Bergman, M. Lundholm, D. Holmberg, and S. L. Cardell
Prevention of Diabetes in Nonobese Diabetic Mice Mediated by CD1d-Restricted Nonclassical NKT Cells
J. Immunol., September 1, 2004; 173(5): 3112 - 3118.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.